KIF4A and central nervous system cancer: To this end, Yan et al. recently mined gene expression and drug response data available in the Connectivity Map and identified WZ-3146 as a putative KIF4A inhibitor, reporting that it downregulated KIF4A expression and exhibited anti-cancer effects in glioma models [52].